Retatrutide sodium salt NEW
| Price | $247 | $622 | $997 |
| Package | 1mg | 5mg | 10mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-09-17 |
Product Details
| Product Name: Retatrutide sodium salt | Purity: 99.97% |
| Supply Ability: 10g | Release date: 2025/09/17 |
Product Introduction
Bioactivity
| Name | Retatrutide sodium salt |
| Description | Retatrutide sodium salt is a potent triple agonist peptide for glucagon receptor (GCGR), glucose-dependent proinsulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R) Retatrutide sodium salt is used in the study of type 2 diabetes and obesity. |
| In vitro | Retatrutide sodium salt exhibits activity against human GCGR, GIPR, and GLP-1R, with EC50 values of 5.79, 0.0643, and 0.775 nM, respectively[1]. In mouse models, Retatrutide sodium salt demonstrates activity against GCGR, GIPR, and GLP-1R, with EC50 values of 2.32, 0.191, and 0.794 nM, respectively[1]. The binding affinities of Retatrutide sodium salt for human GCGR, GIPR, and GLP-1R are characterized by Ki values of 5.6, 0.057, and 7.2 nM, respectively[1]. For mouse GCGR, GIPR, and GLP-1R, Retatrutide sodium salt exhibits binding affinities with Ki values of 73, 2.8, and 1.3 nM, respectively[1]. |
| In vivo | Retatrutide sodium salt, administered via subcutaneous injection at a single dose of 0.47 mg/kg, engages with the glucagon receptor (GCGR) in vivo and improves glucose tolerance in an intraperitoneal glucose tolerance test (ipGTT) through activation of GIP or GLP-1 receptors[1]. With subcutaneous injections at a dose of 10 mL/kg every 3 days for a cycle of 21 days, Retatrutide sodium salt induces significant weight loss and increased energy expenditure through activation of the glucagon-like peptide-1 (GLP-1) receptor[1]. Retatrutide sodium salt demonstrates safety and tolerability in these studies[1]. |
| Storage | store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | GlucagonReceptor | Glucagon Receptor | GLP-1 | GCGR | Flagelin22sodiumsalt(304642919freebase) |
| Inhibitors Related | PF-06882961 Tris | PF-06882961 | Exendin-4 acetate | Semaglutide | (S, R)-LSN 3318839 | NNC 92-1687 | Adomeglivant | 6α-Methylprednisolone 21-hemisuccinate sodium salt | MK-0626 | Orforglipron | Tirzepatide Acetate(2023788-19-2 free base) | LSN3318839 |
| Related Compound Libraries | Peptide Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $80.00/1Box |
VIP1Y
|
GUANGZHOU SHENGYOU IM&EX CO,.LTD
|
2025-09-28 | |
| $75.00/1Box |
VIP1Y
|
Hebei Kenwei Packaging Products Co., LTD
|
2025-09-26 | |
| $0.00/1box |
VIP1Y
|
Shanghai Yimeixin Technology Co., LTD
|
2025-09-24 | |
| $1.00/10g |
VIP1Y
|
Hainan Fubai Trading Co., LTD
|
2025-09-22 | |
| $0.00/25kg |
VIP1Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2025-09-18 | |
| $85.00/1boxbox |
VIP1Y
|
Hebei Lutong Import and Export Co., Ltd
|
2025-09-18 | |
| $0.00/1kg |
VIP2Y
|
Shandong Hanjiang Chemical Co., Ltd
|
2025-09-10 | |
| $0.00/1g |
VIP2Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2025-09-10 | |
| $0.00/1g |
VIP1Y
|
Shandong Juntai Pharmaceutical Co. , Ltd.
|
2025-08-30 | |
| $279.45/1g |
VIP1Y
|
TsurgeX Pharmaceutical Technology Co., Ltd.
|
2025-08-26 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY